Literature DB >> 27747070

Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.

Juergen Kast1.   

Abstract

Entities:  

Year:  2016        PMID: 27747070      PMCID: PMC5059315          DOI: 10.21037/jtd.2016.08.80

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  21 in total

Review 1.  Non-small cell lung cancer: current treatment and future advances.

Authors:  Cecilia Zappa; Shaker A Mousa
Journal:  Transl Lung Cancer Res       Date:  2016-06

Review 2.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

Review 3.  MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines.

Authors:  Joseph D Comber; Ramila Philip
Journal:  Ther Adv Vaccines       Date:  2014-05

Review 4.  The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis.

Authors:  Manav Korpal; Yibin Kang
Journal:  RNA Biol       Date:  2008 Jul-Sep       Impact factor: 4.652

5.  Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression.

Authors:  Joachim Dissemond; Petra Goette; Janet Moers; Anette Lindeke; Manfred Goos; Soldano Ferrone; Stephan N Wagner
Journal:  Melanoma Res       Date:  2003-08       Impact factor: 3.599

Review 6.  The promise and potential pitfalls of chimeric antigen receptors.

Authors:  Michel Sadelain; Renier Brentjens; Isabelle Rivière
Journal:  Curr Opin Immunol       Date:  2009-03-25       Impact factor: 7.486

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 8.  Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis.

Authors:  Kanwaljit Brar; Donald Y M Leung
Journal:  Expert Opin Biol Ther       Date:  2016-03-03       Impact factor: 4.388

9.  MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.

Authors:  Mark Cobbold; Hugo De La Peña; Andrew Norris; Joy M Polefrone; Jie Qian; Ann Michelle English; Kara L Cummings; Sarah Penny; James E Turner; Jennifer Cottine; Jennifer G Abelin; Stacy A Malaker; Angela L Zarling; Hsing-Wen Huang; Oliver Goodyear; Sylvie D Freeman; Jeffrey Shabanowitz; Guy Pratt; Charles Craddock; Michael E Williams; Donald F Hunt; Victor H Engelhard
Journal:  Sci Transl Med       Date:  2013-09-18       Impact factor: 17.956

10.  Interferon-γ Inhibits Ebola Virus Infection.

Authors:  Bethany A Rhein; Linda S Powers; Kai Rogers; Manu Anantpadma; Brajesh K Singh; Yasuteru Sakurai; Thomas Bair; Catherine Miller-Hunt; Patrick Sinn; Robert A Davey; Martha M Monick; Wendy Maury
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

View more
  3 in total

1.  From biological mechanisms to clinical implications: the role of mineral dust-induced gene in lung cancers.

Authors:  Jianjun Zhang; Hongwen Zhao
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers.

Authors:  Miseon Lee; In Hye Song; Sun-Hee Heo; Young-Ae Kim; In Ah Park; Won Seon Bang; Hye Seon Park; Gyungyub Gong; Hee Jin Lee
Journal:  Cancer Res Treat       Date:  2018-02-26       Impact factor: 4.679

3.  USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression.

Authors:  Bing Han; Yue Sun; Dongdong Yang; Huijuan Zhang; Steven Mo; Xuesong Chen; Hailing Lu; Xueyan Mao; Jing Hu
Journal:  Aging (Albany NY)       Date:  2020-04-15       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.